• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number T505
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aortic Regurgitation (1716)
Event Date 11/01/2011
Event Type  Injury  
Manufacturer Narrative
Citation: bedogni et al.Transcatheter valve-in-valve implantation using corevalve revalving system for failed surgical aortic bioprostheses.Jacc cardiovasc interv.2011 nov;4(11):1228-34.Doi: 10.1016/j.Jcin.2011.10.002.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the performance of transcatheter valve-in-valve implantation in patients with a degenerated aortic bioprosthetic valve.All data were collected from multiple centers prior to 2011.The study population included 25 patients (mean age 82.4 years) with a stenotic or regurgitant bioprosthetic valve.Four patients had previously implanted medtronic mosaic (3) or hancock (1) bioprosthetic valves.All patients were implanted with a medtronic corevalve (25).No serial numbers were provided.Among the four medtronic surgical valve patients, all valves were noted with aortic regurgitation which required intervention.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HANCOCK II AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key8174005
MDR Text Key130654530
Report Number2025587-2018-03451
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P980043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 12/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberT505
Device Catalogue NumberT505
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age82 YR
-
-